Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,304 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV.
Gay CL, Bosch RJ, McKhann A, Moseley KF, Wimbish CL, Hendrickx SM, Messer M, Furlong M, Campbell DM, Jennings C, Benson C, Overton ET, Macatangay BJC, Kuritzkes DR, Miller E, Tressler R, Eron JJ, Hardy WD; A5370 Team. Gay CL, et al. Among authors: benson c. J Acquir Immune Defic Syndr. 2021 Aug 15;87(5):e234-e236. doi: 10.1097/QAI.0000000000002716. J Acquir Immune Defic Syndr. 2021. PMID: 33929394 Free PMC article. Clinical Trial. No abstract available.
Regional adipose tissue and elevations in serum aminotransferases in HIV-infected individuals.
Tien PC, Kotler DP, Overton ET, Lewis CE, Rimland D, Bacchetti P, Scherzer R, Gripshover B; Study of Fat Redistribution and Metabolic Change in HIV Infection Investigators. Tien PC, et al. J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):169-76. doi: 10.1097/QAI.0b013e3181685700. J Acquir Immune Defic Syndr. 2008. PMID: 18285711 Free PMC article.
Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.
Abraham AG, D'Souza G, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, Saag MS, Rourke SB, Rachlis A, Napravnik S, Moore RD, Klein MB, Kitahata MM, Kirk GD, Hogg RS, Hessol NA, Goedert JJ, Gill MJ, Gebo KA, Eron JJ, Engels EA, Dubrow R, Crane HM, Brooks JT, Bosch RJ, Strickler HD; North American AIDS Cohort Collaboration on Research and Design of IeDEA. Abraham AG, et al. J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):405-13. doi: 10.1097/QAI.0b013e31828177d7. J Acquir Immune Defic Syndr. 2013. PMID: 23254153 Free PMC article.
A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy.
Jacobson JM, Wang H, Bordi R, Zheng L, Gross BH, Landay AL, Spritzler J, Routy JP, Benson C, Aberg J, Tebas P, Haas DW, Tiu J, Coughlin K, Purdue L, Sekaly RP; AIDS Clinical Trials Group (ACTG) A5212 Protocol Team. Jacobson JM, et al. Among authors: benson c. J Acquir Immune Defic Syndr. 2014 Aug 1;66(4):399-406. doi: 10.1097/QAI.0000000000000195. J Acquir Immune Defic Syndr. 2014. PMID: 24815851 Free PMC article. Clinical Trial.
1,304 results